DCP - Back to School Survey

21 September 2020 / Posted in: Information, Support

Following the success of the Disabled Children's Partnership's survey in the spring about being #LeftinLockdown, they have launched this new survey to gather information on how the return to school has gone for disabled children. Deadline to take part is 5th October.

Read full story

COVID-19 - Survey on Flying with a Disability

21 September 2020 / Posted in: Information, Support

Josh Wintersgill, who has SMA, is the founder and director of easyTravelseat. They are running a survey to gather views around how disabled people feel about flying in the current climate, and to find out more about the impact that Covid-19 has had.

Read full story

Early Access to Medicines Scheme (EAMS) announced for Risdiplam in the UK

17 September 2020 / Posted in: Treatments & Research

Today, the Medicines and Healthcare Products Regulatory Agency (MRHA) announced access to Risdiplam for those who have SMA Type 1 or Type 2, aged 2 months and older, who are not suitable for authorised treatments.

Read full story

Left In Lockdown - DCP Survey Results

15 September 2020 / Posted in: Information, Support

Back in May, the Disabled Children's Partnership ran a survey to understand more about the impact the coronavirus pandemic and lockdown was having on disabled children and young people, their siblings and parents. Over 4,000 people completed the survey. Read about the results.

Read full story

Biogen: September Community Update on European / Global Access to Nusinersen

14 September 2020 / Posted in: Treatments & Research

Biogen has provided the latest update on access to nusinersen treatment around the world. 29 European countries now have access to nusinersen via regular reimbursement.

Read full story

Muscular Dystrophy UK - SMA Seminar

14 September 2020 / Posted in: Information, Treatments & Research, Support

The first seminar of their 'MDUK Muscles Matter 2020' series took place during SMA Awareness Month and was an update on research into SMA and a panel discussion on potential treatments and managing the condition. Watch it here.

Read full story

AveXis Renamed Novartis Gene Therapies

03 September 2020 / Posted in: Treatments & Research

Novartis has renamed the previously acquired AveXis - the pharmaceutical company behind the gene therapy treatment, Zolgensma - to Novartis Gene Therapies. The change signifies the growing importance of gene therapy.

Read full story

Same But Different - 'A Glimmer of Hope' Calendar Photography Competition

03 September 2020 / Posted in: Information, Support

The winning images will be used to create a calendar that will celebrate the people behind rare conditions, as well as helping to raise awareness. The competition is open now and runs until the 22nd September.

Read full story

New Extensions to the Access To Work Scheme Announced

02 September 2020 / Posted in: Information, Support

Covid-19 is changing the way we work and impacting working environments and arrangements. With many employers asking workers to adapt to a new environment, Access to Work can play a key role in supporting disabled people to retain, return to and move into employment.

Read full story

SMA Europe and Partners Launch the European Alliance for Newborn Screening

31 August 2020 / Posted in: Treatments & Research

Early diagnosis and treatment of SMA leads to better outcomes. Launched today, on the last day of SMA Awareness Month, this Alliance brings together all stakeholders (EAMDA, EURORDIS, TREAT-NMD, AveXis, Biogen, and Roche) with the aim, by 2025, for newborn screening programmes in Europe to include a test for SMA.

Read full story